World Vaccine Congress Europe 2018

World Vaccine Congress Europe 2018

World Vaccine Congress Europe 2018 will be taking place on 29-31 October in Lisbon, Portugal, a conference to provide research, development and strategic partnering for the global vaccine industry.

With an award-winning series of conferences and the largest vaccine exhibition meeting of its kind around the world, the World Vaccine Congress Europe 2018 is a place for numerous industry professionals to network with.

It’s the 19th year for the congress and is co-located with the 4th World Vaccine Veterinary Congress and 3rd Immune Profiling World Congress.

How many people will be attending World Vaccine Congress Europe 2018?

At the congress, there will be 500 plus potential customers attending, which will present opportunities to find contacts who need solutions to the challenges in:

  • Manufacturing
  • Clinical trials
  • Strategy
  • Regulation
  • Veterinary vaccines
  • Immune profiling
  • Respiratory, influenza, therapeutic and emerging disease vaccines.

It is the chance to meet decision makers in the areas that are most applicable for whatever business offering you have.

Who are the key speakers?

Throughout the congress there will be numerous presentations from key figures within the industry. Key speakers for the event are:

  • Lord James (Jim) O’Neil
    Honorary Professor of Economics
    University of Manchester & Author of AMR Review UK
  • Ana Maria Henao-Restrepo MD
    Team Leader, Implementation Research Initiative for Vaccine Research
    World Health Organization (WHO)
  • Emily Erbelding
    M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases
    NIAID/NIH
  • Dr Melanie Saville
    Director of Vaccine Development
    CEPI
  • Dr Thomas G. Evans
    CEO
    Vaccitech
  • Dr Laszlo Radvanyi
    Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology
    EMD Serono
  • Dr Rino Rappuoli
    Chief Scientist
    GSK Vaccines
  • Ruxandra Draghia-Akli
    Vice President of Vaccines Public Health & Scientific Affairs
    Merck (MSD)
  • Dr Wayne Koff
    President & CEO
    The Human Vaccines Project
  • Professor Helen McShane
    Professor of Vaccinology, Jenner Institute
    Oxford University
  • Dr Alex Duncan
    Chief Technology Officer and Head of Research
    Agenus Inc

How to get involved

If you register today, you can benefit from the 10% partner discount. Just simply use the voucher code RPXN when you register online here.

You can also receive a further 20% off if you book a group of 3 plus people.

LEAVE A REPLY

Please enter your comment!
Please enter your name here